Listed

Healthcare Triangle, Inc.

HCTINasdaqCIK 1839285TechnologyFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$9.2mRevenue, Q2 FY2026, three months to 2026-06-30$9.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 13, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$9.2mRevenue, Q2 FY2026, three months to 2026-06-30$9.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure+158.4% on a year earlier
  • Gross margin22.5%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $2.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Revenue: $9.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure+8.6 pts on a year earlier
  • Operating margin−44.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Revenue: $9.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure−6.1 pts on a year earlier
  • Net margin−48.0%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Revenue: $9.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure−9.6 pts on a year earlier
  • Diluted EPS−$1.56Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure+95.5% on a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$9.2mGross margin 22.5%
Diluted EPS−$1.56, Q2 FY2026
Free cash flow−$6.9m, Q1 FY2026
Healthcare Triangle, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$k2,413Revenue, Q3 FY2024, three months to 2024-09-30$2.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Report this figure2,190Revenue, Q4 FY2024, three months to 2024-12-31$2.2m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Report this figure3,704Revenue, Q1 FY2025, three months to 2025-03-31$3.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Report this figure3,558Revenue, Q2 FY2025, three months to 2025-06-30$3.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure3,489Revenue, Q3 FY2025, three months to 2025-09-30$3.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Report this figure3,139Revenue, Q4 FY2025, three months to 2025-12-31$3.1m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Report this figure9,855Revenue, Q1 FY2026, three months to 2026-03-31$9.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Report this figure9,193Revenue, Q2 FY2026, three months to 2026-06-30$9.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure
Gross margin%0.0%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $0. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-14, accession 0001213900-24-098548. Derived: 9-month figure less the 6-month figure.Revenue: $2.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Report this figure0.0%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $0. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-31, accession 0001213900-25-026218. Derived: 12-month figure less the 9-month figure.Revenue: $2.2m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Report this figure28887.7%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $1.07bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-20, accession 0001213900-25-045994.Revenue: $3.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Report this figure13.9%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $494.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Revenue: $3.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure30644.2%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $1.07bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001213900-25-109581. Derived: 9-month figure less the 6-month figure.Revenue: $3.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Report this figure5256.5%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $165.0m. XBRL concept us-gaap:GrossProfit. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Revenue: $3.1m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Report this figurenot reported (Gross profit not reported)22.5%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $2.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Revenue: $9.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure
Operating margin%(48.4%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Revenue: $2.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Report this figure(22.7%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$498.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Revenue: $2.2m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Report this figure(37.7%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Revenue: $3.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Report this figure(38.2%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Revenue: $3.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure(74.3%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Revenue: $3.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Report this figure(141.5%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Revenue: $3.1m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Report this figure(36.8%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Revenue: $9.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Report this figure(44.3%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Revenue: $9.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure
Net margin%(51.8%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Revenue: $2.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Report this figure(61.6%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Revenue: $2.2m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Report this figure(45.9%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Revenue: $3.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Report this figure(38.4%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Revenue: $3.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure(54.6%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Revenue: $3.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Report this figure(143.5%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Revenue: $3.1m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Report this figure(62.9%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$6.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Revenue: $9.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Report this figure(48.0%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Revenue: $9.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure
Diluted EPS$ per share(54.78)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$54.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Report this figurenot reported (Diluted EPS not reported)(0.17)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Report this figure(35.01)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$35.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure(0.42)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001213900-25-109581.Report this figurenot reported (Diluted EPS not reported)(6.81)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$6.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Report this figure(1.56)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089241.Report this figure
Free cash flow$knot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)(1,500)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001213900-25-109581. Derived: 9-month figure less the 6-month figure.Capital expenditure: $3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001213900-25-109581. Derived: 9-month figure less the 6-month figure.Report this figure(6,834)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K/A filed 2026-04-16, accession 0001213900-26-044671. Derived: 12-month figure less the 9-month figure.Report this figure(6,886)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Capital expenditure: $22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001213900-26-056096.Report this figurenot reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$13.9mGross margin 8890.6%
Diluted EPS−$152.30, FY2025
Free cash flow−$16.5m, FY2025
Healthcare Triangle, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m35.3Revenue, FY2021, twelve months to 2021-12-31$35.3m. XBRL concept us-gaap:Revenues. 10-K filed 2023-03-28, accession 0001607062-23-000154.Report this figure45.9Revenue, FY2022, twelve months to 2022-12-31$45.9m. XBRL concept us-gaap:Revenues. 10-K/A filed 2025-02-18, accession 0001213900-25-014503.Report this figure33.2Revenue, FY2023, twelve months to 2023-12-31$33.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-31, accession 0001213900-25-026218.Report this figure11.7Revenue, FY2024, twelve months to 2024-12-31$11.7m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Report this figure13.9Revenue, FY2025, twelve months to 2025-12-31$13.9m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)3222.6%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $1.07bn. XBRL concept us-gaap:GrossProfit. 10-K/A filed 2025-02-18, accession 0001213900-25-014503.Revenue: $33.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-31, accession 0001213900-25-026218.Report this figure9148.4%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $1.07bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-31, accession 0001213900-25-026218.Revenue: $11.7m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Report this figure8890.6%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $1.24bn. XBRL concept us-gaap:GrossProfit. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Revenue: $13.9m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Report this figure
Operating margin%(15.2%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-28, accession 0001607062-23-000154.Revenue: $35.3m. XBRL concept us-gaap:Revenues. 10-K filed 2023-03-28, accession 0001607062-23-000154.Report this figure(35.6%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$16.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2025-02-18, accession 0001213900-25-014503.Revenue: $45.9m. XBRL concept us-gaap:Revenues. 10-K/A filed 2025-02-18, accession 0001213900-25-014503.Report this figure(23.2%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001213900-25-026218.Revenue: $33.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-31, accession 0001213900-25-026218.Report this figure(40.6%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$4.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Revenue: $11.7m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Report this figure(70.5%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$9.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Revenue: $13.9m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Report this figure
Net margin%(16.9%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-28, accession 0001607062-23-000154.Revenue: $35.3m. XBRL concept us-gaap:Revenues. 10-K filed 2023-03-28, accession 0001607062-23-000154.Report this figure(31.3%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$14.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2025-02-18, accession 0001213900-25-014503.Revenue: $45.9m. XBRL concept us-gaap:Revenues. 10-K/A filed 2025-02-18, accession 0001213900-25-014503.Report this figure(26.2%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001213900-25-026218.Revenue: $33.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-31, accession 0001213900-25-026218.Report this figure(51.0%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Revenue: $11.7m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Report this figure(68.2%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$9.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Revenue: $13.9m. XBRL concept us-gaap:Revenues. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Report this figure
Diluted EPS$ per share(0.20)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2022-03-08, accession 0001607062-22-000176.Report this figure(3.88)Diluted EPS, FY2022, twelve months to 2022-12-31−$3.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K/A filed 2025-02-18, accession 0001213900-25-014503.Report this figure(2.08)Diluted EPS, FY2023, twelve months to 2023-12-31−$2.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-31, accession 0001213900-25-026218.Report this figure(16909.30)Diluted EPS, FY2024, twelve months to 2024-12-31−$16909.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Report this figure(152.30)Diluted EPS, FY2025, twelve months to 2025-12-31−$152.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)(5.4)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2025-02-18, accession 0001213900-25-014503.Capital expenditure: $40.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K/A filed 2025-02-18, accession 0001213900-25-014503.Report this figure(2.2)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001213900-25-026218.Capital expenditure: $12.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001213900-25-026218.Report this figurenot reported (Capital expenditure not reported)(16.5)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$16.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Capital expenditure: $6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K/A filed 2026-04-16, accession 0001213900-26-044671.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Healthcare Triangle, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BANK OF MONTREAL /CAN/2026-06-30$36.2k20,000Added+10,000
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$21.7k11,975Reduced−620
UBS Group AG2026-06-30$16.0k8,859Reduced−31,856
Tower Research Capital LLC (TRC)2026-06-30$2.4k1,314Added+520
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$1.6k859Unchanged
BARCLAYS PLC2026-06-30$561310New+310
JPMORGAN CHASE & CO2026-06-30$3820New+20
DANSKE BANK A/S2026-06-30$21Unchanged

Recent filings

All 262 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Healthcare Triangle, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-2317:20 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001213900-26-112193
2026-10-1317:20 ETDEF 14AProxy statementPeriod 2026-10-230001213900-26-109104
2026-10-0217:20 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001213900-26-106533
2026-09-2517:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-26-103604
2026-09-0813:56 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-26-097953
2026-08-1317:16 ET10-QQuarterly reportPeriod 2026-06-300001213900-26-089241
2026-07-2907:10 ET8-K3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-26-082514
2026-07-2016:05 ET8-K5.07 Shareholder vote results0001213900-26-079616
2026-07-1017:15 ETS-1Registration statement0001213900-26-077268
2026-06-2617:00 ETDEF 14AProxy statementPeriod 2026-07-170001213900-26-072691

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Apr 15, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1839285
Tickers
HCTI
Exchange
Nasdaq
SIC code
7373 Services-Computer Integrated Systems Design
Sector
Technology
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 17:16 ET. Listed shows no prices and gives no investment advice.